SI2533758T1 - Farmacevtski pelet, ki vsebuje epidermalni rastni faktor za oralno dejanje - Google Patents

Farmacevtski pelet, ki vsebuje epidermalni rastni faktor za oralno dejanje

Info

Publication number
SI2533758T1
SI2533758T1 SI201130525T SI201130525T SI2533758T1 SI 2533758 T1 SI2533758 T1 SI 2533758T1 SI 201130525 T SI201130525 T SI 201130525T SI 201130525 T SI201130525 T SI 201130525T SI 2533758 T1 SI2533758 T1 SI 2533758T1
Authority
SI
Slovenia
Prior art keywords
growth factor
epidermal growth
orally administrable
administrable pharmaceutical
pharmaceutical pellet
Prior art date
Application number
SI201130525T
Other languages
English (en)
Inventor
Gomez Raimundo Ubieta
Barreto Ana Aguilera
Diaz Eduardo Martinez
Meireles Rolando Paez
Guerra Antonio Sereno
Original Assignee
Centro De Ingenieria Genetica Y Biotecnologia (Cigb)
Biorec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Ingenieria Genetica Y Biotecnologia (Cigb), Biorec S.A. filed Critical Centro De Ingenieria Genetica Y Biotecnologia (Cigb)
Publication of SI2533758T1 publication Critical patent/SI2533758T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI201130525T 2010-02-12 2011-02-10 Farmacevtski pelet, ki vsebuje epidermalni rastni faktor za oralno dejanje SI2533758T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10382033A EP2364690A1 (en) 2010-02-12 2010-02-12 Orally administrable pharmaceutical pellet of epidermal growth factor
EP11702645.0A EP2533758B1 (en) 2010-02-12 2011-02-10 Orally administrable pharmaceutical pellet of epidermal growth factor
PCT/EP2011/051918 WO2011098499A1 (en) 2010-02-12 2011-02-10 Orally administrable pharmaceutical pellet of epidermal growth factor

Publications (1)

Publication Number Publication Date
SI2533758T1 true SI2533758T1 (sl) 2015-08-31

Family

ID=42355395

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201130525T SI2533758T1 (sl) 2010-02-12 2011-02-10 Farmacevtski pelet, ki vsebuje epidermalni rastni faktor za oralno dejanje

Country Status (21)

Country Link
US (1) US9205130B2 (sl)
EP (2) EP2364690A1 (sl)
JP (1) JP5778184B2 (sl)
KR (1) KR101745750B1 (sl)
CN (1) CN102753146B (sl)
AR (1) AR080144A1 (sl)
AU (1) AU2011214421B8 (sl)
BR (1) BR112012020223B8 (sl)
CA (1) CA2789055C (sl)
DK (1) DK2533758T3 (sl)
ES (1) ES2537704T3 (sl)
HR (1) HRP20150643T1 (sl)
HU (1) HUE024986T2 (sl)
MX (1) MX2012009217A (sl)
PL (1) PL2533758T3 (sl)
PT (1) PT2533758E (sl)
RS (1) RS54098B1 (sl)
RU (1) RU2540503C2 (sl)
SI (1) SI2533758T1 (sl)
SM (1) SMT201500158B (sl)
WO (1) WO2011098499A1 (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102432737B (zh) * 2011-09-07 2015-02-25 张绍国 一种缓释肠溶丙烯酸树脂乳胶液及其制法
EP3482771B1 (en) * 2013-03-14 2023-01-18 Société des Produits Nestlé S.A. Manufacture of peanut formulations for oral desensitization
CN113966229A (zh) 2019-05-10 2022-01-21 爱沐疗法公司 用于改善花生过敏患者的生活质量的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62149622A (ja) 1985-12-24 1987-07-03 Wakunaga Pharmaceut Co Ltd 腸機能改善剤
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof
DE3778275D1 (de) * 1986-08-07 1992-05-21 Roehm Gmbh Verfahren zur herstellung eines redispergierbaren kunststoffpulvers.
JPH01246223A (ja) 1988-03-28 1989-10-02 Hitachi Chem Co Ltd 潰瘍治療剤
US5272135A (en) * 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides
WO1999030671A2 (en) * 1997-12-15 1999-06-24 Ron Eyal S Aspected particles for oral delivery
US20030104996A1 (en) 2001-08-30 2003-06-05 Tiansheng Li L-methionine as a stabilizer for NESP/EPO in HSA-free formulations
CN101912601B (zh) 2002-06-21 2012-08-29 诺和诺德医疗保健公司 因子vii多肽的稳定化固体组合物
US20040126358A1 (en) 2002-09-16 2004-07-01 Warne Nicholas W. Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
DE10332160A1 (de) * 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
AR045068A1 (es) * 2003-07-23 2005-10-12 Univ Missouri Formulacion de liberacion inmediata de composiciones farmaceuticas
WO2005058345A1 (en) 2003-12-16 2005-06-30 University Technologies International Inc. A treatment for necrotizing enterocolitis
WO2007095288A2 (en) * 2006-02-13 2007-08-23 Nektar Therapeutics Methionine-containing protein or peptide compositions and methods of making and using
MXPA06013015A (es) * 2006-11-09 2007-02-07 Gastronomia Molecular S A Nuevo proceso de elaboracion y estabilidad de un producto nutritivo de amaranto.
CA2734275A1 (en) * 2008-09-10 2010-03-18 Genentech, Inc. Compositions and methods for the prevention of oxidative degradation of proteins

Also Published As

Publication number Publication date
DK2533758T3 (da) 2015-06-22
EP2364690A1 (en) 2011-09-14
WO2011098499A1 (en) 2011-08-18
AR080144A1 (es) 2012-03-14
PT2533758E (pt) 2015-08-26
KR20120114402A (ko) 2012-10-16
AU2011214421B8 (en) 2014-01-30
EP2533758A1 (en) 2012-12-19
US9205130B2 (en) 2015-12-08
BR112012020223B8 (pt) 2021-05-25
PL2533758T3 (pl) 2015-10-30
CA2789055A1 (en) 2011-08-18
KR101745750B1 (ko) 2017-06-09
ES2537704T3 (es) 2015-06-11
JP2013519649A (ja) 2013-05-30
BR112012020223A2 (pt) 2017-07-04
RS54098B1 (en) 2015-10-30
AU2011214421A1 (en) 2012-08-23
SMT201500158B (it) 2015-09-07
RU2012139030A (ru) 2014-03-20
US20120308661A1 (en) 2012-12-06
RU2540503C2 (ru) 2015-02-10
CN102753146B (zh) 2014-11-26
CA2789055C (en) 2017-07-18
AU2011214421B2 (en) 2013-12-19
HRP20150643T1 (hr) 2015-08-14
JP5778184B2 (ja) 2015-09-16
EP2533758B1 (en) 2015-04-08
CN102753146A (zh) 2012-10-24
HUE024986T2 (en) 2016-01-28
BR112012020223B1 (pt) 2021-05-11
AU2011214421A8 (en) 2014-01-30
MX2012009217A (es) 2012-11-23

Similar Documents

Publication Publication Date Title
ZA201308086B (en) Derivatives of 1-anino-2-cyclopropylboronic acid
IL226231A0 (en) A formulation of lacosamide that is administered once a day
ZA201308851B (en) Storage of respiratory produce
IL222548A0 (en) Novel hydroxamic acid derivative
IL225812A0 (en) Data structure of an age-appropriate nutritional formula with probiotics
EP2798063A4 (en) PREPARATION OF DIHYDROSTERCULINIC ACID AND DERIVATIVES THEREOF
EP2601279A4 (en) SUPERTORREFICATION FROM BIOMASS TO BIO COAL
LT2648696T (lt) Nauja racekadotrilio skyrimo forma
PL2648551T3 (pl) Fermentowany preparat do żywienia niemowląt
HK1169379A1 (en) Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof 3-
EP2563768A4 (en) MANUFACTURE OF FEBUXOSTAT
GB201004096D0 (en) Production of polyhydroalkanoates
GB201008573D0 (en) Biocatalytic production of cellobiosides
SI2533758T1 (sl) Farmacevtski pelet, ki vsebuje epidermalni rastni faktor za oralno dejanje
IL224192A (en) Compositions of Vitamin 14 – Epi Analogs d
EP2603459A4 (en) SYNTHESIS OF STANNAN AND DEUTEROSTANNAN
PT2603319E (pt) Processo para a preparação de uretanos
EP2536688A4 (en) STABLE DOSAGE FORMS OF LEVOMILNACIPRAN
GB201001203D0 (en) Use of pharmaceutically active compounds
HUP1100272A2 (en) Pharmaceutical use of silicic acid
GB201301307D0 (en) Crystalline form of prulifloxacin and processes for its preparation
RS20110018A3 (en) COMBINED TABLET FORM AND PROCEDURES FOR ITS OBTAINING IT
GB201003342D0 (en) Manufacture of insoluble drugs
TWM390745U (en) Structure improvement of tea-making can
TWM389918U (en) Improved structure of transformer